SB312 Alabama 2022 Session

This bill would prohibit an occupational licensing board from taking adverse action against a physician who recommends a COVID-19 treatment that is not FDA-approved

This bill would require a patient's written, informed consent to receive a physician's recommended COVID-19 treatment if the treatment is not FDA-approved

This bill would require pharmacies to fulfill prescriptions that are not FDA-approved to treat COVID-19

This bill would require health care facilities to provide a patient's requested off-label COVID-19 treatment

This bill would provide a cause of action against an occupational licensing board, pharmacy, or health care facility that violates the provisions of this bill

This bill would also provide that a health care facility, pharmacy, and licensing board that complies with this bill is immune from civil liability related to certain COVID-19 treatments

Relating to COVID-19; to prohibit an occupational licensing board from taking adverse action against a physician who recommends certain COVID-19 treatments; to require a patient's written, informed consent to certain COVID-19 treatments; to require health care facilities and pharmacies to provide certain COVID-19 treatments that are not approved by the FDA; to provide immunity to licensing boards, pharmacies, and health care facilities; and to create a cause of action.